NCT00599495
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University Medical Center Hamburg-Eppendorf Hamburg, Germany
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,014 public trials
2,030 recruiting studies
Immunoproliferative Disorders trial results
Completed
A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)
NCT03455140
- Conditions
- Cancer, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Women's & Children's Hospital Adelaide, Australia
- Queensland Children's Hospital Brisbane, Australia
- Royal Children's Hospital Melbourne Melbourne, Australia
- Perth Children's Hospital Perth, Australia
NCT03619252
- Conditions
- Agranulocytosis, Bacterial Infections, Bacterial Infections and Mycoses, +32 more
- Locations
-
- Minsk Scientific Practical Center of Surgery, Transplantation and Hematology, Belarus Minsk, Belarus
Completed
Concussion Active Rehabilitation
NCT04248218
- Conditions
- Brain Concussion, Brain Diseases, Brain Injuries, +23 more
- Locations
-
- Children's National Medical Center Washington D.C., District of Columbia, United States
NCT03036904
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +10 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Weill Cornell Medicine New York, United States
- Ohio State University Medical Center Columbus, Ohio, United States
Completed
Lenalidomide Monotherapy in R/R DLBCL
NCT04150328
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- MorphoSys Research Site Rochester, Minnesota, United States
- MorphoSys Research Site St Louis, Missouri, United States
- MorphoSys Research Site Manhasset, New York, United States
- MorphoSys Research Site New York, United States
NCT00549848
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Completed
Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma.
NCT02292979
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- ZNA Middelheim Antwerp, Belgium
- ZNA Stuivenberg Antwerp, Belgium
- A.Z. Sint Jan AV Bruges, Belgium
- Institut Jules Bordet Brussels, Belgium
NCT00199082
- Conditions
- Burkitt Lymphoma, Burkitt's Leukemia, Burkitt's Lymphoma, +30 more
- Locations
-
- University Hospital, Medical Dept. II Frankfurt, Germany
NCT03580408
- Conditions
- Coexisting Medical Conditions, Hemic and Lymphatic Diseases, Hodgkin Disease, +8 more
- Locations
-
- ZNA Stuivenberg Antwerp, Belgium
- Az Sint Jan Bruges, Belgium
- Clinique Universitaire Saint LUC Brussels, Belgium
- Institut Jules Bordet Brussels, Belgium